Akeso has now been advised to submit a sNDA to Chinese regulators for cadonilimab’s approval in gastric cancer by an ...
SAN FRANCISCO and SUZHOU, China, Dec. 25, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
Innovent Biologics Inc., a biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of innovative drugs for major diseases including oncology, autoimmune ...
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with ...
SurvivorNet on MSN
Cancer patients are living longer — a closer look at the treatments driving this progress
New data show cancer survival has reached a record high — nearly 70% of patients now live at least five years after diagnosis ...
TABOSUN ® (ipilimumab N01 injection) has been approved in combination with TYVYT ® (sintilimab injection) for the neoadjuvant treatment of patients with stage IIB-III resectable microsatellite ...
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as ...
Michał Nowakowski, joint CEO at CD Projekt, the parent company of The Witcher and Cyberpunk 2077 developer, shut down a question during an earnings webcast about AI being used to "reduce headcount." ...
The two largest credit card companies have agreed to a multi-million-dollar settlement in a class-action lawsuit concerning ATM fees. Reuters reported Visa and Mastercard will pay a combined $167.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback